In vivo analysis of wild-type and FTDP-17 tau transgenic mice

Annals of the New York Academy of Sciences

Volumn 920, Issue , 2000, Pages 126-133

  Gotz J ^a   Barmettler, R ^b   Ferrari, A ^c   Goedert, M ^a   Probst, A ^b   Nitsch, R M ^c  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; TAU PROTEIN;

ANIMAL CELL; ANIMAL MODEL; CHROMOSOME 17; CONFERENCE PAPER; CONTROLLED STUDY; DENDRITE; EXON; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; GENETIC ANALYSIS; GENETIC LINKAGE; IMMUNOREACTIVITY; IN VIVO STUDY; MOUSE; MUSCLE ATROPHY; MUSCLE WEAKNESS; NERVE CELL LESION; NERVE FIBER; NEUROFIBRILLARY TANGLE; NONHUMAN; PARKINSON DISEASE; PHENOTYPE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS; WALLERIA;

EID: 0034531599     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06914.x     Document Type: Conference Paper

References (24)

1. Molecular dissection of the paired helical filament
2. Tau regulates the attachment/detachment but not the speed of motors in microtubule-dependent transport of single vesicles and organelles
3. Expression of separate isoforms of human tau protein: Correlation with the tau pattern in brain and effects on tubulin polymerization
4. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
5. Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform
6. Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease
7. Two amyloid precursor protein transgenic mouse modsels with Alzheimer disease-like pathology
8. Silver staining of Alzheimer's neurofibrillary changes by means of physical development
9. SOD1 mutation is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis
10. A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice
11. Alzheimer-like changes in microtubule-associated protein Tau induced by sulfated glycosaminoglycans. Inhibition of microtubule binding, stimulation of phosphorylation, and filament assembly depend on the degree of sulfation
12. Presence of tau in isolated nuclei from human brain
13. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures
14. From neuronal inclusions to neurodegeneration: Neuropathological investigation of a transgenic mouse model of Huntington's disease
15. Staging of Alzheimer's disease-related neurofibrillary changes
16. A novel pool of protein phosphatase 2A is associated with microtubules and is regulated during the cell cycle
17. Delayed embryonic lethality in mice lacking protein phosphatase 2A catalytic subunit Calpha
18. The role of protein phosphatase 2A catalytic subunit Calpha in embryogenesis: Evidence from sequence analysis and localization studies
19. Functional expression of human PP2Ac in yeast permits the identification of novel C-terminal and dominant-negative mutant forms
20. Familial dementia caused by polymerization of mutant neuroserpin
21. Altered microtubule organization in small-calibre axons of mice lacking tau protein
22. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein
23. Tau filament formation in transgenic mice expressing P301L tau